Thirty-day Treatment Continuation After Audio-only Buprenorphine Telehealth Initiation
暂无分享,去创建一个
B. Jacka | C. Davis | E. Samuels | R. Wightman | B. Hallowell | Seth Clark | Claire Pratty | Caroline A Wunsch
[1] D. Yealy,et al. Use of a Telemedicine Bridge Clinic to Engage Patients in Opioid Use Disorder Treatment , 2022, Journal of addiction medicine.
[2] B. Tofighi,et al. Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19 , 2022, Journal of General Internal Medicine.
[3] R. Chou,et al. Opioid Treatment Programs, Telemedicine and Covid-19: A Scoping Review , 2021, Substance abuse.
[4] L. Degenhardt,et al. Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis. , 2021, JAMA psychiatry.
[5] K. Knight,et al. Covid-19: A Catalyst for Change in Telehealth Service Delivery for Opioid Use Disorder Management , 2021, Substance abuse.
[6] J. Weiss,et al. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic , 2021, Journal of Substance Abuse Treatment.
[7] V. Ferrari,et al. Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic , 2020, JAMA network open.
[8] C. Davis,et al. Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19 , 2020, International Journal of Drug Policy.
[9] B. Marshall,et al. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States , 2020, JAMA network open.
[10] N. Volkow. Stigma and the Toll of Addiction. , 2020, The New England journal of medicine.
[11] K. Brady,et al. Implementation of emergency department–initiated buprenorphine for opioid use disorder in a rural southern state , 2020, Journal of substance abuse treatment.
[12] Ryan D. Ross,et al. Buprenorphine Treatment Divide by Race/Ethnicity and Payment. , 2019, JAMA psychiatry.
[13] J. Eibl,et al. The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. , 2017, Drug and alcohol dependence.
[14] Wanhong Zheng,et al. Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis , 2017, Journal of addiction medicine.
[15] H. Knudsen,et al. Adoption and Implementation of Medications in Addiction Treatment Programs , 2011, Journal of addiction medicine.